Benchmark's initiation adds a fresh bullish voice to a stock already heavily favored by analysts, but the real edge lies in the insider buying and extreme short interest. Traders should watch for a squeeze if the stock breaks above resistance; the near-term EPS weakness makes this a tactical rather than core long position.
How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 9 $75.78entry
- T+1 · 5mo ago −2.05%α −0.47% · $74.23
- T+5 · 5mo ago +3.40%α +0.99% · $78.36
- T+20 · 4mo ago +7.98%α +6.54% · $81.83
- T+60 · 3mo ago +14.73%α +10.91% · $86.94
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Benchmark initiated coverage on IFF at Buy with a $100 price target, implying 36% upside from the current $73.56 close. The firm is one of the most active covering the stock, with a 54% accuracy rate on 1,703 calls and an average return of 6%. Consensus on IFF is overwhelmingly bullish: 15 of 21 analysts rate it Buy (71.4%), 6 Hold, and none Sell. The mean price target is $91.16, with a range of $71 to $105, placing Benchmark's $100 target well above the mean. Momentum is lopsided, only one analyst action in the past 30 days (this initiation) and zero downgrades, but near-term EPS revisions have turned negative (9 downgrades vs 1 upgrade for the current quarter), creating a divergence. Insider buying adds a confirming bullish signal, with executives Fribourg and Fyrwald purchasing over $2M in March and June. However, the short interest ratio of 75.1% reflects heavy bearish positioning, making the analyst call a potential contrarian bet against crowded shorts. The high short interest combined with insider accumulation creates a tactical squeeze opportunity for traders willing to look past near-term earnings caution.
Impact Score
Consensus & Targets
The consensus among 21 analysts covering IFF is strongly bullish: 5 Strong Buy, 10 Buy, and 6 Hold, with zero Sell/Strong Sell ratings. That translates to 71.4% Buy-equivalent ratings and 28.6% Hold, reflecting broad optimism despite recent share weakness.
The mean price target is $91.16, median $92, with a high of $105 and a low of $71. At $73.56, the stock trades at a 19.3% discount to the mean target. Benchmark's $100 target ranks near the top of the range, above both the mean and median, and is just 4.8% below the street-high of $105.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-09 | Benchmark | initiate | Buy | $100.00 |
| 2026-05-08 | Barclays | maintain | Overweight | $90.00 |
| 2026-05-07 | Citigroup | maintain | Buy | $96.00 |
| 2026-05-07 | JP Morgan | maintain | Overweight | $92.00 |
| 2026-05-07 | Oppenheimer | maintain | Outperform | $90.00 |
| 2026-04-22 | Oppenheimer | maintain | Outperform | $88.00 |
| 2026-04-14 | Barclays | maintain | Overweight | $80.00 |
| 2026-04-13 | Citigroup | maintain | Buy | $90.00 |
| 2026-04-09 | UBS | maintain | Neutral | $75.00 |
| 2026-02-17 | Barclays | maintain | Overweight | $91.00 |
In the past 30 days, there has been 1 upgrade (this initiation) and 0 downgrades. EPS revision trends are mixed: long-term estimates have risen (10 up, 3 down for the current fiscal year; 12 up, 3 down for next year), but near-term quarterly estimates are under pressure, the current quarter has 9 downward revisions vs 1 upward, and the next quarter has 6 down vs 4 up. This suggests analysts are hedging on short-term execution while looking past it for the year.
Firm Track Record: Benchmark
Benchmark accuracy: 54% on 1703 calls | avg return: 6%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 13 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Mizuho | 75% | 3/4 | 0% | top tier |
| Stifel | 60% | 3/5 | -1.9% | above average |
| Citigroup | 57% | 4/7 | 3.5% | above average |
| Morgan Stanley | 57% | 4/7 | 2.9% | above average |
| Argus Research | 50% | 1/2 | -1.5% | below average |
| Tigress Financial | 50% | 1/2 | -4.8% | below average |
| Oppenheimer | 40% | 2/5 | -3.9% | below average |
| UBS | 38% | 3/8 | 0.5% | below average |
| B of A Securities | 33% | 1/3 | 3.9% | below average |
| Wells Fargo | 33% | 2/6 | 1.6% | below average |
Benchmark has a 54% accuracy rate on 1,703 rated stocks, with an average return of 6%. Among firms covering IFF, the best performers by accuracy are Mizuho (75% on 4 calls) and Stifel (60% on 5 calls), while the worst are JP Morgan (0% on 5) and Baird (0% on 2). Benchmark's accuracy places it in the middle-to-upper tier, ahead of UBS (38%), BofA (33%), and Barclays (22%).
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0y | $4.49 | $4.25 to $4.77 | $10.6B | ↑0 ↓0 |
| +1y | $4.78 | $4.27 to $5.25 | $10.6B | ↑1 ↓0 |
| +1q | $1.14 | $1.07 to $1.23 | $2.7B | ↑0 ↓0 |
| 0q | $1.12 | $1.05 to $1.14 | $2.7B | ↑0 ↓0 |
Cross-Platform Signals
Insider trades align strongly with the bullish call: CEO Fyrwald bought $933k in March and $62k in March, and director Fribourg bought $995k in March and $1M on June 1, a clear cluster of insider accumulation. Institutional flows show a mixed picture: Renaissance Technologies nearly exited (-96.6%), while Norges Bank both entered and exited. Short interest is extreme, 75.1% short ratio, implying heavy bearish bets. The convergence of insider buying and analyst initiation against extreme short interest creates a potential squeeze setup, but the institutional exits add caution.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
13 reports on IFF
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $81.16 Now $79.99 −1.44% settles Feb 11
- Nov 3, 202613d ago 8-K Neutral 3/10 Entry $87.67 Now $79.99 −8.76% settles Feb 2
- Nov 3, 202613d ago 8-K Neutral 5/10 Entry $87.67 Now $79.99 −8.76% settles Feb 2
- Oct 30, 202617d ago Institutional Cluster Neutral 2/10 Entry $93.02 Now $79.99 −14.01% settles Jan 28
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $90.66 Now $79.99 −11.77% settles Jan 26
- Sep 11, 20269w ago ANALYST-UPGRADE Neutral 2/10 Entry $83.61 Now $79.99 −4.33% settles Dec 7
- Aug 10, 202614w ago Insider Cluster Neutral 2/10 Entry $85.00 to $87.67 Now $79.99 −5.89% ▲ +3.14% +3.63% vs SPY
- Jul 20, 202617w ago Press Release Neutral 3/10 Entry $76.26 to $88.20 Now $79.99 +4.89% ▲ +15.66% +11.68% vs SPY
- Jun 23, 202620w ago 8-K Neutral 4/10 Entry $75.83 to $84.91 Now $79.99 +5.49% ▲ +11.97% +9.14% vs SPY
- Jun 9, 202622w ago ANALYST-UPGRADE Bullish 3/10 Viewing Entry $75.78 to $86.94 Now $79.99 +5.56% ▲ +14.73% +10.91% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers